Congress Asset Management CO Ardelyx, Inc. Transaction History

Congress Asset Management CO

  • $14.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 28, 2022
SELL
$0.86 - $1.7 $828,683 - $1.64 Million
-963,586 Closed
0 $0
Q3 2021

Nov 08, 2021
BUY
$1.27 - $8.17 $798,423 - $5.14 Million
628,680 Added 187.72%
963,586 $1.27 Million
Q2 2021

Aug 05, 2021
BUY
$6.55 - $8.98 $2.19 Million - $3.01 Million
334,906 New
334,906 $2.54 Million

Others Institutions Holding ARDX

# of Institutions
218
Shares Held
141M
Call Options Held
1.08M
Put Options Held
2M
View Full List

About ARDELYX, INC.

ARDX Quotes by TradingView
  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $742M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Congress Asset Management CO Portfolio

Follow Congress Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Asset Management CO , based on Form 13F filings with the SEC.

News

Stay updated on Congress Asset Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email